World Orphan Drug Congress

Date: 2 November 2020 - 5 November 2020

Melia Sitges Hotel Resort
Carrer de Joan Salvat Papasseit, 38

Website: www.terrapinn.com/WODC/DTR/Info

The World Orphan Drug Congress is an award-winning event with an exhibition that has grown to become the largest and most established orphan drugs & rare diseases meeting of its kind across the globe.

Now in its 11th annual edition, the World Orphan Drug Congress Europe, together with the co-located Cell & Gene Therapy Congress, will continue to bring experts from the whole value chain under one roof, where you get to meet decision makers in the areas that are most applicable for your business offering.

Now recognised as the largest and most established multi-stakeholder rare disease meeting, we are once again proud to deliver another outstanding speaker line-up and a content-filled agenda organised around 15 tracks, including:

  • cell & gene therapies
  • genetic testing
  • gene editing
  • partnering & investment
  • global market access

… and so much more!

Here are just some of the great experts helping us build a rich programme, as part of our Advisory Board:

  • Yann Le Cam, CEO, EURORDIS
  • Rick Thompson, CEO, Findacure
  • Durhane Wong-Rieger, President & CEO, Canadian Organization for Rare Disorders
  • Dr Ségolène Aymé, Founder of Orphanet, Emeritus Research Director, INSERM
  • Steve Groft, Senior Advisor to Director, NCATS, NIH
  • Dr Josep Torrent-Farnell, Former Head of the Medicines Divison, CatSalut
  • Alastair Kent, Former Director, Genetic Alliance UK
  • Sheela Upadhyaya, Former Associate Director Highly Specialised Technologies, NICE
  • Dr Bruno Sepodes, Chair of COMP, EMA
  • Dr Pedro Franco, Former Scientific Administrator, EMA

To download the programme, please visit: http://terrapinn.com/WODC/DTR/Speakers

To book your ticket, please visit: http://terrapinn.com/WODC/DTR/Book


Loading Map....

Related topics

Related organisations

Send this to a friend